Prabhudas Lilladher's research report on NOCIL
NOCIL reported revenue of Rs3.4bn (PLe: Rs3bn; Consensus: Rs3.6bn), reflecting 5% YoY decline but 7% QoQ increase. The topline was impacted by ~5% drop in sales volume YoY and marginal decline in the specialty product mix. Based on our estimates, average realizations stood flat YoY at Rs255/kg. Sales volume declined 5% YoY but grew 4% sequentially. However, EBITDA /kg fell 20% YoY, primarily due to higher operating leverage, resulting in a 240bps YoY contraction in EBITDA margin. Capacity utilization remained at 65%, with significant variation across product lines. To meet rising demand for select rubber chemicals, with plants already operating at high utilization levels, like TDQ antioxidants, the company is investing Rs2.5bn in capacity expansion. These additional capacities are expected to come online in H2FY27, though peak utilization across the portfolio may take another 1.5–2 years. Low-price dumping from China, Korea and the EU continues to pose a key risk. However, any imposition of ADD on NOCIL’s products could help improve performance going forward.
Outlook
The stock is currently trading at ~24x FY27 EPS. We maintain our ‘Reduce’ rating with a target price of Rs172, valuing the company at 22x FY27 EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.